Zhang, M., Yao, Z., Dubois, S., Ju, W., Müller, J. R., & Waldmann, T. A. (2009). Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer. National Academy of Sciences.
Dyfyniad Arddull ChicagoZhang, Meili, Zhengsheng Yao, Sigrid Dubois, Wei Ju, Jürgen R. Müller, and Thomas A. Waldmann. Interleukin-15 Combined With an Anti-CD40 Antibody Provides Enhanced Therapeutic Efficacy for Murine Models of Colon Cancer. National Academy of Sciences, 2009.
Dyfyniad MLAZhang, Meili, et al. Interleukin-15 Combined With an Anti-CD40 Antibody Provides Enhanced Therapeutic Efficacy for Murine Models of Colon Cancer. National Academy of Sciences, 2009.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.